Ana Sofia Coroadinha interview on Gene Therapy

In an interview to TSF, Ana Sofia Coroadinha, head of the Cell Line Development and Molecular Virology Lab, comments on the future developments of gene editing and gene therapy.

This is the fourth episode of a series of 5 interviews resulting from a collaborative initiative between CIB - Centro de Informação de Biotecnologia and TSF.

Click here to access all the interviews (in Portuguese).

Selected interview highlights:

• Gene therapy is a therapeutic strategy enabling treating a genetic condition by editing patients' own genes.
• There is a growing number of approved gene therapy drugs and drug candidates, using classical gene therapy strategies.
• None of the approved drugs employ genome editing techniques such as CRISPR. Nonetheless, in the last two years, promising progresses were reported in clinical trials [using genome editing techniques] addressing, for example, β thalassemias and amyloidosis.